HMPL-306 (ranosidenib)
NCT07025018
Hutchmed · Phase 1 · Recruiting · Enrollment 52
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
HMPL-306 (ranosidenib)
Hutchmed · Phase 1 · Recruiting · Enrollment 52
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.